e-learning
resources
Munich 2014
Monday, 08.09.2014
Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microarray analysis of long non-coding RNAs in COPD
X. Yao, H. Bi, J. Zhou, M. Huang, I. Adcock, P. Barnes (Nanjing, China; London, United Kingdom)
Source:
International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Session:
Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Session type:
Poster Discussion
Number:
2031
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Yao, H. Bi, J. Zhou, M. Huang, I. Adcock, P. Barnes (Nanjing, China; London, United Kingdom). Microarray analysis of long non-coding RNAs in COPD. Eur Respir J 2014; 44: Suppl. 58, 2031
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Microarray cluster analysis reveals individual genes and biological processes associated with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Expression analysis of different alpha-1 antitrypsin transcripts by quantitative PCR
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Metabolomic profiling of the lung in a murine model of emphysema
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Pathophysiology of asthma: From endotype to phenotype
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Mining common pathway deregulation profiles in lung diseases
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Asthma and myeloperoxidase gene promoter region polymorphism
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Re-sequencing of
PLAUR
in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
The asthma-COPD overlap syndrome: Transcription factors GATA3 and STAT6 as possible markers
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
The impact of budesonide/formoterol on the airway transcriptome in COPD
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Identification and distribution of rare and new mutations of Alpha-1-antitrypsin in Germany
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Age-dependent influence of ADRB2 gene polymorphisms on asthma severity in Serbian population
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Methylation associated pathway activity deregulation in lung adenocarcinoma
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Lung under experimental atherosclerosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomes
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
The role of
Foxc2
gene in lung development
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Gene set variation analysis of mRNA expression in bronchial biopsies from the U-BIOPRED asthma study
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept